Article (Périodiques scientifiques)
Mutations in RHOT1 disrupt ER-mitochondria contact sites interfering with calcium homeostasis and mitochondrial dynamics in Parkinson's disease.
GROSSMANN, Dajana; BERENGUER, Clara; Bellet, Marie Estelle et al.
2019In Antioxidants and Redox Signaling
Peer reviewed
 

Documents


Texte intégral
Grossmann2019.AntioxRedoxSign.pdf
Postprint Auteur (2.9 MB)
Demander un accès

Tous les documents dans ORBilu sont protégés par une licence d'utilisation.

Envoyer vers



Détails



Mots-clés :
RHOT1; Miro1; Parkinson's disease; mitochondria; mitochondrial shape transition; ER-mitochondrial contact
Résumé :
[en] OBJECTIVE: The outer mitochondrial membrane protein Miro1 is a crucial player in mitochondrial dynamics and calcium homeostasis. Recent evidence indicated that Miro1 mediates calcium-induced mitochondrial shape transition (MiST), which is a prerequisite for the initiation of mitophagy. Moreover, altered Miro1 protein levels have emerged as a shared feature of monogenic and sporadic Parkinson's disease (PD), but, so far, no disease-associated variants in RHOT1 have been identified. RESULTS: Here, for the first time, we describe heterozygous RHOT1 mutations in two PD patients (het c.815G>A; het c.1348C>T) and identified mitochondrial phenotypes with reduced mitochondrial mass in patient-derived cellular models. Both mutations lead to decreased ER-mitochondrial contact sites and calcium dyshomeostasis. As a consequence, energy metabolism was impaired, which in turn lead to increased mitophagy. CONCLUSION: In summary, our data support the role of Miro1 in maintaining calcium homeostasis and mitochondrial quality control in PD.
Centre de recherche :
- Luxembourg Centre for Systems Biomedicine (LCSB): Clinical & Experimental Neuroscience (Krüger Group)
- Luxembourg Centre for Systems Biomedicine (LCSB): Bioinformatics Core (R. Schneider Group)
- Luxembourg Centre for Systems Biomedicine (LCSB): Biomedical Data Science (Glaab Group)
- Luxembourg Centre for Systems Biomedicine (LCSB): Integrative Cell Signalling (Skupin Group)
Disciplines :
Neurologie
Génétique & processus génétiques
Auteur, co-auteur :
GROSSMANN, Dajana ;  University of Luxembourg > Luxembourg Centre for Systems Biomedicine (LCSB)
BERENGUER, Clara ;  University of Luxembourg > Luxembourg Centre for Systems Biomedicine (LCSB)
Bellet, Marie Estelle
Scheibner, David
Bohler, Jill
MASSART, François  ;  University of Luxembourg > Luxembourg Centre for Systems Biomedicine (LCSB)
Rapaport, Doron
SKUPIN, Alexander  ;  University of Luxembourg > Luxembourg Centre for Systems Biomedicine (LCSB)
FOUQUIER D'HÉROUËL, Aymeric ;  University of Luxembourg > Luxembourg Centre for Systems Biomedicine (LCSB)
Sharma, Manu
GHELFI, Jenny ;  University of Luxembourg > Luxembourg Centre for Systems Biomedicine (LCSB)
Rakovic, Aleksandar
Lichtner, Peter
ANTONY, Paul ;  University of Luxembourg > Luxembourg Centre for Systems Biomedicine (LCSB)
GLAAB, Enrico  ;  University of Luxembourg > Luxembourg Centre for Systems Biomedicine (LCSB)
MAY, Patrick  ;  University of Luxembourg > Luxembourg Centre for Systems Biomedicine (LCSB)
Dimmer, Kai Stefan
Fitzgerald, Julia Catherine
GRÜNEWALD, Anne  ;  University of Luxembourg > Luxembourg Centre for Systems Biomedicine (LCSB)
KRÜGER, Rejko ;  University of Luxembourg > Faculty of Science, Technology and Communication (FSTC) > Life Science Research Unit
Plus d'auteurs (10 en +) Voir moins
Co-auteurs externes :
yes
Langue du document :
Anglais
Titre :
Mutations in RHOT1 disrupt ER-mitochondria contact sites interfering with calcium homeostasis and mitochondrial dynamics in Parkinson's disease.
Date de publication/diffusion :
15 juillet 2019
Titre du périodique :
Antioxidants and Redox Signaling
ISSN :
1523-0864
eISSN :
1557-7716
Peer reviewed :
Peer reviewed
Focus Area :
Systems Biomedicine
Projet européen :
H2020 - 692320 - CENTRE-PD - TWINNING for a Comprehensive Clinical Centre for the Diagnosis and Treatment of Parkinson's Disease
Projet FnR :
FNR11676395 - Mitochondrial Risk Factors In Parkinson's Disease, 2017 (01/03/2018-31/08/2021) - Rejko Krüger
Intitulé du projet de recherche :
MiRisk-PD
Organisme subsidiant :
FNR: PEARL (P13/6682797/Krüger), MiRisk-PD (MiRisk‐PD, C17/BM/11676395), CASCAD (7975668), INTER/BMBF/13/04, NCER-PD, FNR9631103.
DFG: KR2119/8‐1, DI 1386/2‐1, FOR2488
NIH: P41 GM103426
BMBF: Mito‐PD 031 A 430
JPND Courage-PD
CE - Commission Européenne
European Union
Disponible sur ORBilu :
depuis le 22 juillet 2019

Statistiques


Nombre de vues
415 (dont 37 Unilu)
Nombre de téléchargements
5 (dont 3 Unilu)

citations Scopus®
 
66
citations Scopus®
sans auto-citations
54
OpenCitations
 
45
citations OpenAlex
 
77
citations WoS
 
65

Bibliographie


Publications similaires



Contacter ORBilu